Acelrx Pharma (ACRX) Files 5.55M Common Shelf for Shareholders
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Join SI Premium – FREE
Acelrx Pharmaceuticals, Inc. (Nasdaq: ACRX) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 5,552,440 shares of its common stock on behalf of selling shareholders.
The company will not receive proceeds from the secondary offering.
The company will not receive proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leader's Advantage Acquisition Corp. closes $150M IPO on Nasdaq
- FDA approves Atebrioz for rare bone-forming disease in patients 12 and up
- CrowdStrike probe closed by US prosecutors without charges
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
